Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology

Klebsiella pneumoniae is a Gram-negative pathogen of clinical relevance, which can provoke serious urinary and blood infections and pneumonia. This bacterium is a major public health threat due to its resistance to several antibiotic classes. Using a reverse vaccinology approach, 7 potential antigen...

Full description

Bibliographic Details
Main Authors: Nicola Cuscino, Ayesha Fatima, Vincenzo Di Pilato, Matteo Bulati, Caterina Alfano, Elisa Monaca, Giuseppina Di Mento, Daniele Di Carlo, Francesca Cardinale, Francesco Monaco, Gian Maria Rossolini, Asif M. Khan, Pier Giulio Conaldi, Bruno Douradinha
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037022003695
_version_ 1797978156902121472
author Nicola Cuscino
Ayesha Fatima
Vincenzo Di Pilato
Matteo Bulati
Caterina Alfano
Elisa Monaca
Giuseppina Di Mento
Daniele Di Carlo
Francesca Cardinale
Francesco Monaco
Gian Maria Rossolini
Asif M. Khan
Pier Giulio Conaldi
Bruno Douradinha
author_facet Nicola Cuscino
Ayesha Fatima
Vincenzo Di Pilato
Matteo Bulati
Caterina Alfano
Elisa Monaca
Giuseppina Di Mento
Daniele Di Carlo
Francesca Cardinale
Francesco Monaco
Gian Maria Rossolini
Asif M. Khan
Pier Giulio Conaldi
Bruno Douradinha
author_sort Nicola Cuscino
collection DOAJ
description Klebsiella pneumoniae is a Gram-negative pathogen of clinical relevance, which can provoke serious urinary and blood infections and pneumonia. This bacterium is a major public health threat due to its resistance to several antibiotic classes. Using a reverse vaccinology approach, 7 potential antigens were identified, of which 4 were present in most of the sequences of Italian carbapenem-resistant K. pneumoniae clinical isolates. Bioinformatics tools demonstrated the antigenic potential of these bacterial proteins and allowed for the identification of T and B cell epitopes. This led to a rational design and in silico characterization of a multiepitope vaccine against carbapenem-resistant K. pneumoniae strains. As adjuvant, the mycobacterial heparin-binding hemagglutinin adhesin (HBHA), which is a Toll-like receptor 4 (TLR-4) agonist, was included, to increase the immunogenicity of the construct. The multiepitope vaccine candidate was analyzed by bioinformatics tools to assess its antigenicity, solubility, allergenicity, toxicity, physical and chemical parameters, and secondary and tertiary structures. Molecular docking binding energies to TLR-2 and TLR-4, two important innate immunity receptors involved in the immune response against K. pneumoniae infections, and molecular dynamics simulations of such complexes supported active interactions. A codon optimized multiepitope sequence cloning strategy is proposed, for production of recombinant vaccine in classical bacterial vectors. Finally, a 3 dose-immunization simulation with the multiepitope construct induced both cellular and humoral immune responses. These results suggest that this multiepitope construct has potential as a vaccination strategy against carbapenem-resistant K. pneumoniae and deserves further validation.
first_indexed 2024-04-11T05:19:35Z
format Article
id doaj.art-7ba7f4e86ad14e7bab076f47bcd67e1a
institution Directory Open Access Journal
issn 2001-0370
language English
last_indexed 2024-04-11T05:19:35Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Computational and Structural Biotechnology Journal
spelling doaj.art-7ba7f4e86ad14e7bab076f47bcd67e1a2022-12-24T04:54:01ZengElsevierComputational and Structural Biotechnology Journal2001-03702022-01-012044464463Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinologyNicola Cuscino0Ayesha Fatima1Vincenzo Di Pilato2Matteo Bulati3Caterina Alfano4Elisa Monaca5Giuseppina Di Mento6Daniele Di Carlo7Francesca Cardinale8Francesco Monaco9Gian Maria Rossolini10Asif M. Khan11Pier Giulio Conaldi12Bruno Douradinha13Dipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalyBeykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Istanbul, TurkeySOD Microbiologia e Virologia, Azienda Ospedaliera Universitaria Careggi, Florence, ItalyDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalyUnità di Biologia Strutturale e Biofisica, Fondazione Ri.MED, Palermo, ItalyUnità di Biologia Strutturale e Biofisica, Fondazione Ri.MED, Palermo, ItalyDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalyDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalyDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalyDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalySOD Microbiologia e Virologia, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Florence, ItalyBeykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Istanbul, Turkey; Centre for Bioinformatics, School of Data Sciences, Perdana University, Damansara Heights, Kuala Lumpur, MalaysiaDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, ItalyDipartimento di Ricerca, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo, Italy; Unità di Medicina Rigenerativa ed Immunologia, Fondazione Ri.MED, Palermo, Italy; Corresponding author at: Fondazione Ri.MED c/o IRCCS-ISMETT, Via Ernesto Tricomi 5, Palermo 90127, Italy.Klebsiella pneumoniae is a Gram-negative pathogen of clinical relevance, which can provoke serious urinary and blood infections and pneumonia. This bacterium is a major public health threat due to its resistance to several antibiotic classes. Using a reverse vaccinology approach, 7 potential antigens were identified, of which 4 were present in most of the sequences of Italian carbapenem-resistant K. pneumoniae clinical isolates. Bioinformatics tools demonstrated the antigenic potential of these bacterial proteins and allowed for the identification of T and B cell epitopes. This led to a rational design and in silico characterization of a multiepitope vaccine against carbapenem-resistant K. pneumoniae strains. As adjuvant, the mycobacterial heparin-binding hemagglutinin adhesin (HBHA), which is a Toll-like receptor 4 (TLR-4) agonist, was included, to increase the immunogenicity of the construct. The multiepitope vaccine candidate was analyzed by bioinformatics tools to assess its antigenicity, solubility, allergenicity, toxicity, physical and chemical parameters, and secondary and tertiary structures. Molecular docking binding energies to TLR-2 and TLR-4, two important innate immunity receptors involved in the immune response against K. pneumoniae infections, and molecular dynamics simulations of such complexes supported active interactions. A codon optimized multiepitope sequence cloning strategy is proposed, for production of recombinant vaccine in classical bacterial vectors. Finally, a 3 dose-immunization simulation with the multiepitope construct induced both cellular and humoral immune responses. These results suggest that this multiepitope construct has potential as a vaccination strategy against carbapenem-resistant K. pneumoniae and deserves further validation.http://www.sciencedirect.com/science/article/pii/S2001037022003695Klebsiella pneumoniaeReverse vaccinologyAntimicrobial resistanceCarbapenemsSubunit vaccineBioinformatics
spellingShingle Nicola Cuscino
Ayesha Fatima
Vincenzo Di Pilato
Matteo Bulati
Caterina Alfano
Elisa Monaca
Giuseppina Di Mento
Daniele Di Carlo
Francesca Cardinale
Francesco Monaco
Gian Maria Rossolini
Asif M. Khan
Pier Giulio Conaldi
Bruno Douradinha
Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
Computational and Structural Biotechnology Journal
Klebsiella pneumoniae
Reverse vaccinology
Antimicrobial resistance
Carbapenems
Subunit vaccine
Bioinformatics
title Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
title_full Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
title_fullStr Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
title_full_unstemmed Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
title_short Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
title_sort computational design and characterization of a multiepitope vaccine against carbapenemase producing klebsiella pneumoniae strains derived from antigens identified through reverse vaccinology
topic Klebsiella pneumoniae
Reverse vaccinology
Antimicrobial resistance
Carbapenems
Subunit vaccine
Bioinformatics
url http://www.sciencedirect.com/science/article/pii/S2001037022003695
work_keys_str_mv AT nicolacuscino computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT ayeshafatima computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT vincenzodipilato computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT matteobulati computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT caterinaalfano computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT elisamonaca computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT giuseppinadimento computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT danieledicarlo computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT francescacardinale computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT francescomonaco computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT gianmariarossolini computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT asifmkhan computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT piergiulioconaldi computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology
AT brunodouradinha computationaldesignandcharacterizationofamultiepitopevaccineagainstcarbapenemaseproducingklebsiellapneumoniaestrainsderivedfromantigensidentifiedthroughreversevaccinology